tirzepatide pcos fertility Hit follow and comment “GLP” PCOS & Tirzepatide: Mounjaro vs

23-25 The FDA-approved indication for weight management use of GLP-1 RAs is a BMI of 30 or higher, or a BMI of 27 or higher with at least 1 other cardiometabolic comorbidity such as type 2 diabetes or hyperlipidemia

Eating smaller meals, avoiding high-fat foods, and following the gradual dose escalation schedule all help

The Wegovy SmPC advises that semaglutide should be discontinued if pancreatitis is suspected Signs of gallbladder disease including right upper quadrant pain, fever, or jaundice, as GLP-1 receptor agonists and weight loss can increase the risk of gallstones Routine GP consultation is advisable for: Gastrointestinal symptoms persisting beyond 46 weeks without improvement Symptoms significantly impacting quality of life or nutritional intake Unexplained weight loss exceeding expected therapeutic effects New onset of symptoms differing from initial side effects Concerns about symptom severity or medication tolerability NICE guidance on obesity management (TA875) emphasises the importance of regular monitoring during pharmacological weight management interventions

With two uses, I already saw a difference in my face